
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Perspectives |
Williamson Laboratory for Molecular Oncology, Department of Obstetrics and Gynecology, St. Bartholomews and the Royal London School of Medicine and Dentistry, St. Bartholomews Hospital, West Smithfield, London EC1A 7BE, United Kingdom [S. A. B., R. K. I.]; Diagnostica Medica, Centro Fisopatologia della Reproduzione, Mercogliano (AV), Italy [S. A. B.]; and Institute of Health Research, London Metropolitan University, London, United Kingdom N78DB [R. K. I.]
ABSTRACT
Since it was first claimed in 1995 that human chorionic gonadotropin (hCG) inhibits HIV-associated Kaposis sarcoma (KS), focus has been lost on establishing a credible hypothesis to explain a novel action ascribed to hCG, which is, after all, a pregnancy hormone. After 7 years, no real progress has been made, and there remains no consensus as to which component of hCG preparations is responsible for inducing apoptosis of HIV-associated KS. It would certainly seem apparent that many basic experiments on hCG species have been overlooked in the studies that have been published. Furthermore, the much wider literature concerning the association of hCG with promoting oncogenesis has been ignored. This review puts into context the numerous studies on hCG, HIV-associated KS, and oncogenesis.
This article has been cited by other articles:
![]() |
D. Lopez, M. Sekharam, D. Coppola, and W. B. Carter Purified human chorionic gonadotropin induces apoptosis in breast cancer Mol. Cancer Ther., September 1, 2008; 7(9): 2837 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Berndt, S. P. d'Hauterive, S. Blacher, C. Pequeux, S. Lorquet, C. Munaut, M. Applanat, M. A. Herve, N. Lamande, P. Corvol, et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium FASEB J, December 1, 2006; 20(14): 2630 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Malatos, H. Neubert, A. T. Kicman, and R. K. Iles Identification of Placental Transforming Growth Factor-{beta} and Bikunin Metabolites as Contaminants of Pharmaceutical Human Chorionic Gonadotrophin Preparations by Proteomic Techniques Mol. Cell. Proteomics, July 1, 2005; 4(7): 984 - 992. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |